C12N 2750/14121
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2750/14121 (Viruses as such) appears on 245 US grants and 412 published applications in this corpus.
Search patents in C12N- Granted patents
- 245
- Published applications
- 412
- Assignees
- 137
- Inventors
- 461
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 5 |
| 2004 | 1 | 4 |
| 2005 | 0 | 2 |
| 2006 | 2 | 3 |
| 2007 | 3 | 6 |
| 2008 | 1 | 5 |
| 2009 | 0 | 3 |
| 2010 | 3 | 7 |
| 2011 | 1 | 5 |
| 2012 | 2 | 4 |
| 2013 | 4 | 11 |
| 2014 | 8 | 14 |
| 2015 | 8 | 15 |
| 2016 | 13 | 23 |
| 2017 | 14 | 27 |
| 2018 | 15 | 27 |
| 2019 | 17 | 27 |
| 2020 | 25 | 48 |
| 2021 | 23 | 42 |
| 2022 | 21 | 35 |
| 2023 | 26 | 30 |
| 2024 | 25 | 33 |
| 2025 | 18 | 17 |
| 2026 | 13 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof15 Sep 2026US 12,735,459 B2Genzyme Corporation
- DNA impurities in a composition comprising a parvoviral virion7 Jul 2026US 12,674,211 B2uniQure IP B.V.
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs16 Jun 2026US 12,655,427 B2Research Institute At Nationwide Children's Hospital
- Adeno-associated virus (AAV) clade F vector and uses therefor2 Jun 2026US 12,644,101 B2The Trustees of the University of Pennsylvania
- Prostate targeting adeno-associated virus serotype vectors26 May 2026US 12,636,382 B2University of Massachusetts
- Aav9-mediated gene therapy for treating mucopolysaccharidosis type i24 Sep 2026US 2026/0284155 A1The Trustees of the University of Pennsylvania
- Aav vectors targeted to the central nervous system10 Sep 2026US 2026/0263641 A1The University of North Carolina at Chapel Hill
- Adeno-Associated Virus Vector Formulations and Methods13 Aug 2026US 2026/0232743 A1REGENXBIO Inc.
- Inhibition of zbtb7a30 Jul 2026US 2026/0216225 A1Icahn School of Medicine at Mount Sinai
- Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta 1 deficiency30 Jul 2026US 2026/0216372 A1Voyager Therapeutics, Inc.
Most cited
By later US patents
- Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom352US 6,156,303 AUniversity of Washington · 2000
- Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor346US 7,906,111 B2The Trustees of the University of Pennsylvania · 2011
- Method for detecting adeno-associated virus165US 8,524,446 B2The Trustees of the University of Pennsylvania · 2013
- Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same124US 6,759,237 B1The Trustees of the University of Pennsylvania · 2004
- Methods for increasing the efficiency of recombinant AAV product84US 7,229,823 B22007